Effect of Remifentanil on Inos in Lung and Liver Tissue of Septic Mice

Zongze Zhang,Chen Chang,Jianghua Zhan
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2009.11.025
2009-01-01
Abstract:Objective To investigate the effect of remifentanil on the inducible nitric oxide syn-thase (iNOS) expression in lung and liver tissue of the septic mice. Methods Forty male KM mice were randomly divided into four groups (n=10 in each group):sham-operated group (sham group), cecal liga-tion and puncture (CLP) group (CLP group),remifentanil treatment group (R1 group),and remifentanil control group (R2 group). The mouse model of CLP was used to observe arterial partial pressure of oxygen (PaO_2),myeloperoxidase activity,ALT and AST activity,the level of IL-6 and IL-10 in lung and liver tis-sue homogenate. The iNOS protein expression was detected by Western blot. The pathologic changes were observed under an electron microscope. Results Compared with sham group, iNOS protein expression, myeloperoxidase activity, ALT and AST activity, IL-6 and IL-10 (649.74±90.47 and 501.06±57.67 in the lung,341.05±28.73 and 267.50±41.82 in the liver) levels were markedly increased in CLP group (P<0.01), but PaO_2 was significantly reduced (P<0.01). Compared with CLP group, iNOS protein ex-pression,IL-6 and IL-10 levels,myeloperoxidase activity,and ALT and AST activity in R1 group were sig-nificantly decreased (P<0.01). The pathologic changes induced by sepsis were significandy attenuated by remifentanil under the electron microscopy. Conclusion Remifentanil might have a protective effect a-gainst sepsis. Its action mechanisms are probably involved in the inhibition of inflammatory factor produc-tion and suppression of iNOS expression. Key words: Sepsis; Lung injury; Remifentanil; NOS; Inflammatory factor
What problem does this paper attempt to address?